NCT00641225 - Study Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid Arthritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions

Rheumatoid Arthritis

Interventions

DRUG

SBI-087

Single IV doses of SBI-087 from 0.015 mg/kg to 2 mg/kg and Single SC doses of SBI-087 from 50 mg to 300 mg.

Trial Locations (6)

Pfizer Investigational Site, Durham

Pfizer Investigational Site, Miami

Pfizer Investigational Site, Dallas

Pfizer Investigational Site, Edmonton

Pfizer Investigational Site, Toronto

Pfizer Investigational Site, Montreal